|
MAN2A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.70499999996299E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.83176999999368E-05 |
| Normal-vs-Stage2 |
1.823750E-02 |
| Normal-vs-Stage3 |
1.825670E-02 |
| Normal-vs-Stage4 |
8.028000E-02 |
| Stage1-vs-Stage2 |
6.592400E-01 |
| Stage1-vs-Stage3 |
4.521000E-01 |
| Stage1-vs-Stage4 |
9.796800E-01 |
| Stage2-vs-Stage3 |
8.304800E-01 |
| Stage2-vs-Stage4 |
8.006200E-01 |
| Stage3-vs-Stage4 |
6.710800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.65940000002229E-06 |
| Normal-vs-AfricanAmerican |
2.058300E-03 |
| Normal-vs-Asian |
1.409010E-01 |
| Caucasian-vs-AfricanAmerican |
8.734800E-01 |
| Caucasian-vs-Asian |
8.945600E-01 |
| AfricanAmerican-vs-Asian |
8.435000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.83710000440018E-08 |
| Normal-vs-Female |
2.463400E-01 |
| Male-vs-Female |
2.820700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.043800E-01 |
| Normal-vs-Extreme_Weight |
1.79519999998767E-06 |
| Normal-vs-Obese |
1.007700E-04 |
| Normal-vs-Extreme_Obese |
2.437300E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.964830E-01 |
| Normal_Weight-vs-Obese |
5.506000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.857000E-01 |
| Extreme_Weight-vs-Obese |
1.919600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.853400E-01 |
| Obese-vs-Extreme_Obese |
4.849800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.514470E-02 |
| Normal-vs-Age(41-60Yrs) |
4.15110000000496E-05 |
| Normal-vs-Age(61-80Yrs) |
1.587170E-04 |
| Normal-vs-Age(81-100Yrs) |
4.02919999999973E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.031600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.723200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.872600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.177800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.524200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.444400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.05240277498342E-11 |
| Normal-VS-Type2 PRCC |
2.747000E-01 |
| Normal-VS-KIRP CIMP |
8.003800E-01 |
| Normal-VS-Unclassified PRCC |
1.401570E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.157400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.237900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.600280E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.943800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.540800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.845000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.81210000000021E-06 |
| Normal-vs-N1 |
1.218300E-02 |
| Normal-vs-N2 |
7.655800E-01 |
| N0-vs-N1 |
2.689800E-01 |
| N0-vs-N2 |
3.200200E-01 |
| N1-vs-N2 |
6.211600E-01 |
|
|
